2nd Annual Parkinson's Symposium

2nd Annual Parkinson's Symposium
Friday, April 8, 2022
8:00am - 2:15pm (registration opens virtually at 7:30am)
Virtual Event (Free to attend)
Registration Deadline: April 6, 2022 at noon
Registration is required in order to receive the virtual meeting link. The meeting link will be sent to the registration email prior to the event. Space is limited and is "first come, first serve"
For event questions: contact Amy Minsker at the CC CME office at amy.l.minsker@christianacare.org
Overview
Parkinson's Disease is becoming more prevalent with life expectancy increasing and with the number of therapeutics growing every year to treat patients with Parkinson's disease. With more than 1 million Americans suffering from this neurodegenerative disorder and only 50 movement disorder per year graduating from fellowships, care for these patients are more and more being done through primary care and general neurologists. This year's annual Parkinson's Disease symposium will be targeted toward medical professionals to bring them up-to-date with Parkinson's Disease care in 2022 and how to support your patients with resources in our region and here at ChristianaCare.
Target Audience
This activity is intended for Primary Care Physicians, Specialty Physicians, Research Physicians, Physician Assistants, Nurses, Nurse Practitioners, Psychologists, Pharmacists, and all other healthcare professionals.
Statement of Need
Lack of knowledge about Parkinson's disease exists in med school and residencies, including neurology residency.
Lack of movement disorders specialists mean these patients need to be diagnosed and managed many times by both primary care and general neurology.
Lack of knowledge about Parkinson's disease therapies exists in med school and residencies, including neurology residency.
Lack of movement disorders specialists mean these patients need to be treated many times by both primary care and general neurology.
Educational Objectives
Upon completion of this activity learners should be able to:
- Discuss better accuracy for diagnosing Parkinson's Disease.
- Determine appropriate triaging of PD patients to neurologists and movement disorder specialists translating to those who need more specialized care are seen sooner by a specialist.
- Describe improved treatment algorithms for Parkinson's disease with better patient outcomes in motor score and quality of life.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of Delaware and Christiana Care. The Medical Society of Delaware is accredited by the ACCME to provide continuing medical education for physicians.
It is the policy of the Medical Society of Delaware (MSD) to comply with the ACCME Standards for Commercial Support of Continuing Medical Education (CME). In keeping with these standards, all faculty participating in continuing medical education provided by MSD are expected to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations.
Joint providership of CME by MSD in no way implies endorsement of any product or service.
This activity is not supported by commercial funding.
Credit Designation Statement
The Medical Society of Delaware designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Disclosures
In accordance with the appropriate accrediting bodies, all planners, teachers, and authors with control over activity content are required to disclose to the provider any relevant financial relationships (those held by the planner or significant other, currently or within the last 24 months) with commercial interests/ineligible companies. Accredited providers are required to provide this information to learners before the start of an activity.
The following is a list of the faculty, along with any information they have disclosed regarding their relevant financial relationships.
Justin Martello, MD (Planner, Activity Director, Speaker, Moderator) - Abbvie, Adamas, Sunovion, Neurocrine (received speaker fee as speaker) - Best available published evidence will be used to support the presentation. resenting all medication options that exist for PD will be represented and only in list form, with only discussing mechanism of action. All of the relevant financial relationships listed for this individual have been mitigated.
Amy Minsker (Planner, Coordinator) - has no relevant financial relationship(s) with ineligible companies to disclose.
Sarah Hinkle, MSN, APRN, FNP-C (Planner, Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose.
Karen Wilkinson (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose.
Amy Benton, MA, LMSW (Planner, Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose.
Amy Bielicki, CFRE (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose.
Karen Reed, BSN. RN (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose.
Stephen G. Reich, MD, FAAN (Speaker) - Enterin (received consultant fee as Data Safety Monitoring Board Chair); Best Doctors (received consultant fee as consultant); NIH (received research grant as investigator); UpToDate (received reviewer fee as reviewer); Springer/Oxford (receives royalty as book author/editor) - The financial relationships do not relate to the educational assignment/presentation. Best available published evidence will be used to support the presentation. All scientific data used or referenced used as justification of patient care recommendations conforms to the generally accepted standards of experimental design, data collection, and analysis. All of the relevant financial relationships listed for this individual have been mitigated.
Patrick Kerns, MD, PhD (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose.
Linsey O’Donnell, DO (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose.
James Ellison, MD, MPH (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose.
Disclaimer
All information contained within this activity is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this educational event. No single reference or service can take the place of medical training, education and experience. This educational event does not define a standard of care, nor is it intended to dictate an exclusive course of management. This information should not substitute for a visit or consultation with a health care provider.
Technical Requirements
This activity is best experienced using the most current browser of Firefox, Chrome, Safari, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers. To view graphic images and references that appear in separate "pop-up" windows, you must have JavaScript and session cookies enabled on your computer. Adobe Acrobat Reader may be required for certain activities.
Select the Continue button below to begin. You may return later if you are unable to complete the activity at this time.